Stay updated on Seladelpar in PBC & Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.

Latest updates to the Seladelpar in PBC & Hepatic Impairment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedCore content update: new government funding notice with operating status and a new release version (v3.2.0) replacing v3.1.0.SummaryDifference4%

- Check29 days agoChange DetectedUpdate of the page revision tag from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check44 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. This is a minor update focused on versioning and a small UI change.SummaryDifference0.3%

- Check52 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.3%

- Check59 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations in South Korea, as well as drug information related to Seladelpar and primary biliary cholangitis. Notably, the revision number has been updated to v3.0.0.SummaryDifference5%

- Check73 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Seladelpar in PBC & Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC & Hepatic Impairment Clinical Trial page.